The key moments, with employee sentiment along the way.
2013
🌱
2013
Founded around a smart sock
A wearable sock that tracks a sleeping baby's heart rate and oxygen levels, beamed to an anxious parent's phone.
Wikipedia
Jul 2021
📈
Jul 2021
The peak: a $1.07B SPAC debut$1.07B
The Sandbridge Acquisition merger closes in July 2021, putting the Smart Sock maker on the NYSE at unicorn value.
Bloomberg
Oct 2021
Oct 2021
The FDA pulls the sock
A warning letter says the flagship Smart Sock is an uncleared medical device; it comes off the US market, and most of the revenue goes with it.
MobiHealthNews
2022
💔
2022
Slips out of the club
The stock collapses far below its $1.07B debut within a year of listing.
Bloomberg
2022–23
💬
From the inside · Glassdoor reviews, 2022–23
Glassdoor reviews from the 2022-23 trough recalled successive layoff rounds that sapped morale, raises frozen for years, and remaining staff absorbing the work of departed colleagues — even as reviewers kept praising the baby-saving mission.
2023
2023
The sock comes back — cleared this time
Re-engineered products win the FDA clearance the original never had, and the comeback grind begins.
FDA
Today
Today
Still in the club — and still trading
Live · OWLT · NYSEas of 2026-09-17
$4.54▼ 3.20% today≈ $133M cap · −87.6% from peak
💬 entries paraphrase anonymous, unverified reviews posted publicly on Glassdoor ↗; dated facts carry their source.
How it happened
Owlet made the Smart Sock, a wearable tracking a sleeping baby's heart rate and oxygen levels, and went public via a SPAC merger that closed in July 2021 at an enterprise value of about $1.07B.
Months later an FDA warning letter forced the flagship product off the US market, gutting revenue, and the stock collapsed far below its $1B debut.
Source: Bloomberg / MobiHealthNews (~$1.07B enterprise value via Sandbridge Acquisition SPAC, closed July 16 2021; FDA warning letter Oct 2021 forced its Smart Sock off the US market)
